- Home
- SLMBP vs BSX Comparison
SLMBP vs BSX Comparison
Compare SLMBP & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLMBP
- BSX
- Stock Information
- Founded
- SLMBP N/A
- BSX 1979
- Country
- SLMBP United States
- BSX United States
- Employees
- SLMBP 1710
- BSX N/A
- Industry
- SLMBP Finance: Consumer Services
- BSX Medical/Dental Instruments
- Sector
- SLMBP Finance
- BSX Health Care
- Exchange
- SLMBP Nasdaq
- BSX Nasdaq
- Market Cap
- SLMBP N/A
- BSX 138.5B
- IPO Year
- SLMBP N/A
- BSX 1992
- Fundamental
- Price
- SLMBP $73.97
- BSX $101.15
- Analyst Decision
- SLMBP
- BSX Strong Buy
- Analyst Count
- SLMBP 0
- BSX 23
- Target Price
- SLMBP N/A
- BSX $110.26
- AVG Volume (30 Days)
- SLMBP N/A
- BSX 10.6M
- Earning Date
- SLMBP N/A
- BSX 04-23-2025
- Dividend Yield
- SLMBP N/A
- BSX N/A
- EPS Growth
- SLMBP N/A
- BSX 15.23
- EPS
- SLMBP N/A
- BSX 1.37
- Revenue
- SLMBP N/A
- BSX $17,554,000,000.00
- Revenue This Year
- SLMBP N/A
- BSX $15.77
- Revenue Next Year
- SLMBP N/A
- BSX $10.33
- P/E Ratio
- SLMBP N/A
- BSX $73.80
- Revenue Growth
- SLMBP N/A
- BSX 19.36
- 52 Week Low
- SLMBP N/A
- BSX $70.97
- 52 Week High
- SLMBP N/A
- BSX $107.17
- Technical
- Relative Strength Index (RSI)
- SLMBP 58.32
- BSX 58.48
- Support Level
- SLMBP $69.29
- BSX $92.70
- Resistance Level
- SLMBP $71.35
- BSX $102.37
- Average True Range (ATR)
- SLMBP 1.52
- BSX 4.08
- MACD
- SLMBP 0.47
- BSX 0.75
- Stochastic Oscillator
- SLMBP 100.00
- BSX 92.53
About SLMBP SLM Corporation Floating Rate Non-Cumulative Preferred Stock Series B
SLM Corp is an education solutions company. It business is to originate and service loans to students and their families to finance the cost of their education. The provide Private Education Loans to mean education loans to students or their families that are not made, insured, or guaranteed by any state or federal government.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.